文献速递艾滋病与性传播感染

抗逆转录病毒治疗时机:坦桑尼亚人类免疫缺陷病毒感染孕妇的启动时机与出生结局

Timing of Antiretroviral Therapy: Initiation and Birth Outcomes Among Pregnant Women With Human Immunodeficiency Virus in Tanzania.
PubMed 文献 · J Infect Dis · 2022-01-01

该前瞻性队列纳入达累斯萨拉姆1307例妊娠早期或中期启动联合抗逆转录病毒治疗的HIV感染单胎孕妇,按启动时孕龄比较出生结局。孕20周前启动者较20周后启动者早产风险升高(RR 1.30;95%CI 1.03-1.67),小于胎龄儿风险降低(RR 0.71;95%CI 0.55-0.93),胎死或死产风险无关联。

要点

  • 孕20周前启动cART较20周后早产风险升高(RR 1.30;95%CI 1.03-1.67)。
  • 孕20周前启动cART较20周后小于胎龄儿风险降低(RR 0.71;95%CI 0.55-0.93)。
  • 启动时孕龄与胎死或死产风险无关联。

核心结论

  • 随着孕前和妊娠早期cART使用增加,临床医生应了解cART方案对出生结局的获益与潜在风险,以优化出生结局。

研究设计与样本

  • 前瞻性队列研究,纳入达累斯萨拉姆1307例妊娠早期或中期启动cART的HIV感染单胎孕妇。

主要发现

  • 在妊娠期启动cART的妇女中,启动时孕龄与胎死或死产风险无关联。
  • 孕20周前启动cART者较20周后启动者早产风险升高(RR 1.30;95%CI 1.03-1.67)。
  • 孕20周前启动cART者较20周后启动者小于胎龄儿风险降低(RR 0.71;95%CI 0.55-0.93)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Combination antiretroviral therapy (cART) initiation during pregnancy reduces the risk of perinatal human immunodeficiency virus (HIV) transmission; however, studies have suggested that there may be unintended adverse consequences on birth outcomes for selected cART regimens. METHODS: We analyzed adverse birth outcomes among a prospective cohort of 1307 pregnant women with HIV in Dar es Salaam who initiated cART during the first or second trimester of a singleton pregnancy. Our primary analysis compared birth outcomes by gestational age at cART initiation among these women initiating cART in pregnancy. RESULTS: Among women who initiated cART in pregnancy, there was no relationship of gestational age at cART initiation with the risk of fetal death or stillbirth. However, women who initiated cART before 20 weeks of gestation compared with after 20 weeks had increased risk of preterm birth (risk ratio [RR], 1.30; 95% confidence interval [CI], 1.03-1.67) but decreased risk of small-for-gestational age birth (RR, 0.71; 95% CI, .55-.93). CONCLUSIONS: With increasing use of cART preconception and early in pregnancy, clinicians should be aware of the benefits and potential risks of cART regimens to optimize birth outcomes.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Quinn MK, Williams PL, Muhihi A, et al. Timing of Antiretroviral Therapy: Initiation and Birth Outcomes Among Pregnant Women With Human Immunodeficiency Virus in Tanzania. J Infect Dis. 2022. PMID: 35678698. doi:10.1093/infdis/jiac224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。